Cargando...
Use of monoclonal antibody-IRDye800CW bioconjugates in the resection of breast cancer
BACKGROUND: Complete surgical resection of breast cancer is a powerful determinant of patient outcome, and failure to achieve negative margins results in reoperation in between 30% and 60% of patients. We hypothesize that repurposing Food and Drug Administration approved antibodies as tumor-targetin...
Gardado en:
| Publicado en: | J Surg Res |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2013
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4354808/ https://ncbi.nlm.nih.gov/pubmed/24360117 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jss.2013.11.1089 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|